Page last updated: 2024-08-23

paroxetine and Anterior Wall Myocardial Infarction

paroxetine has been researched along with Anterior Wall Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Babongo Bosombo, F; Bernhard, B; Dobner, S; Fürholz, M; Hunziker, L; Lanz, J; Losdat, S; Pilgrim, T; Reusser, N; Siontis, GCM; Stortecky, S; Vollenbroich, R; Windecker, S1
Babongo Bosombo, F; Deckarm, S; Dobner, S; Erne, SA; Fischer, K; Fürholz, M; Gräni, C; Heg, D; Hunziker, L; Lanz, J; Pilgrim, T; Reusser, N; Siontis, GCM; Stark, AW; Stortecky, S; Vollenbroich, R; Windecker, S1

Trials

1 trial(s) available for paroxetine and Anterior Wall Myocardial Infarction

ArticleYear
Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial.
    JAMA cardiology, 2021, 10-01, Volume: 6, Issue:10

    Topics: Anterior Wall Myocardial Infarction; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Paroxetine; Prognosis; Retrospective Studies; ST Elevation Myocardial Infarction; Ventricular Remodeling

2021

Other Studies

1 other study(ies) available for paroxetine and Anterior Wall Myocardial Infarction

ArticleYear
Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition in Patients With Acute Anterior Myocardial Infarction: Final 1-Year Outcomes of the Randomized CARE-AMI Trial.
    Journal of the American Heart Association, 2022, 09-06, Volume: 11, Issue:17

    Topics: Anterior Wall Myocardial Infarction; GTP-Binding Proteins; Humans; Myocardial Infarction; Paroxetine; Randomized Controlled Trials as Topic

2022